Estimation of coronary flow reserve by sestamibi imaging in type 2 diabetic patients with normal coronary arteries

Giovanni Storto, Teresa Pellegrino, Anna Rita Sorrentino, Luca Luongo, Mario Petretta, Alberto Cuocolo

Research output: Contribution to journalArticle

25 Citations (Scopus)

Abstract

Background: We assessed coronary flow reserve (CFR) by sestamibi imaging in patients with type 2 diabetes without coronary artery disease and normal coronary vessels. Methods and Results: Dipyridamole/rest technetium 99m sestamibi imaging was performed in 33 patients with type 2 diabetes without a history of coronary artery disease and normal coronary vessels at angiography and in 12 control subjects. Myocardial blood flow (MBF) was estimated by measuring first-transit counts in the pulmonary artery and myocardial counts from tomographic images. Estimated CFR was expressed as the ratio of stress MBF to rest MBF. Rest MBF and CFR were corrected for rate-pressure product and expressed as normalized MBF and normalized CFR. At rest, estimated MBF and normalized MBF were not different in control subjects versus patients (0.98 ± 0.4 counts · pixel-1 · s-1 vs 1.42 ± 0.9 counts · pixel-1 · s-1 and 1.14 ± 0.5 counts · pixel-1 · s-1 vs 1.61 ± 0.9 counts · pixel-1 · s-1, respectively). Conversely, stress MBF was higher in control subjects than in patients (2.34 ± 0.8 counts · pixel-1 · s-1 vs 1.55 ± 0.8 counts · pixel-1 · s-1, P <.01). Thus estimated CFR was higher in control subjects than in patients (2.40 ± 0.3 vs 1.36 ± 0.8, P <.0001). After correction for the rate-pressure product, normalized CFR was still higher in control subjects than in patients (2.10 ± 0.5 vs 1.28 ± 0.8, P <.001). Conclusions: Sestamibi imaging may detect impaired coronary vascular function in response to dipyridamole in type 2 diabetic patients without a history of coronary artery disease and with normal coronary arteries.

Original languageEnglish
Pages (from-to)194-199
Number of pages6
JournalJournal of Nuclear Cardiology
Volume14
Issue number2
DOIs
Publication statusPublished - Apr 2007

Fingerprint

Coronary Vessels
Coronary Artery Disease
Dipyridamole
Type 2 Diabetes Mellitus
Technetium Tc 99m Sestamibi
Pressure
Pulmonary Artery
Blood Vessels
Angiography

Keywords

  • Coronary flow reserve
  • single photon emission computed tomography imaging
  • type 2 diabetes mellitus

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Estimation of coronary flow reserve by sestamibi imaging in type 2 diabetic patients with normal coronary arteries. / Storto, Giovanni; Pellegrino, Teresa; Sorrentino, Anna Rita; Luongo, Luca; Petretta, Mario; Cuocolo, Alberto.

In: Journal of Nuclear Cardiology, Vol. 14, No. 2, 04.2007, p. 194-199.

Research output: Contribution to journalArticle

Storto, Giovanni ; Pellegrino, Teresa ; Sorrentino, Anna Rita ; Luongo, Luca ; Petretta, Mario ; Cuocolo, Alberto. / Estimation of coronary flow reserve by sestamibi imaging in type 2 diabetic patients with normal coronary arteries. In: Journal of Nuclear Cardiology. 2007 ; Vol. 14, No. 2. pp. 194-199.
@article{b8a5c5769f6e49a7a0f40c8120f013ac,
title = "Estimation of coronary flow reserve by sestamibi imaging in type 2 diabetic patients with normal coronary arteries",
abstract = "Background: We assessed coronary flow reserve (CFR) by sestamibi imaging in patients with type 2 diabetes without coronary artery disease and normal coronary vessels. Methods and Results: Dipyridamole/rest technetium 99m sestamibi imaging was performed in 33 patients with type 2 diabetes without a history of coronary artery disease and normal coronary vessels at angiography and in 12 control subjects. Myocardial blood flow (MBF) was estimated by measuring first-transit counts in the pulmonary artery and myocardial counts from tomographic images. Estimated CFR was expressed as the ratio of stress MBF to rest MBF. Rest MBF and CFR were corrected for rate-pressure product and expressed as normalized MBF and normalized CFR. At rest, estimated MBF and normalized MBF were not different in control subjects versus patients (0.98 ± 0.4 counts · pixel-1 · s-1 vs 1.42 ± 0.9 counts · pixel-1 · s-1 and 1.14 ± 0.5 counts · pixel-1 · s-1 vs 1.61 ± 0.9 counts · pixel-1 · s-1, respectively). Conversely, stress MBF was higher in control subjects than in patients (2.34 ± 0.8 counts · pixel-1 · s-1 vs 1.55 ± 0.8 counts · pixel-1 · s-1, P <.01). Thus estimated CFR was higher in control subjects than in patients (2.40 ± 0.3 vs 1.36 ± 0.8, P <.0001). After correction for the rate-pressure product, normalized CFR was still higher in control subjects than in patients (2.10 ± 0.5 vs 1.28 ± 0.8, P <.001). Conclusions: Sestamibi imaging may detect impaired coronary vascular function in response to dipyridamole in type 2 diabetic patients without a history of coronary artery disease and with normal coronary arteries.",
keywords = "Coronary flow reserve, single photon emission computed tomography imaging, type 2 diabetes mellitus",
author = "Giovanni Storto and Teresa Pellegrino and Sorrentino, {Anna Rita} and Luca Luongo and Mario Petretta and Alberto Cuocolo",
year = "2007",
month = "4",
doi = "10.1016/j.nuclcard.2006.12.327",
language = "English",
volume = "14",
pages = "194--199",
journal = "Journal of Nuclear Cardiology",
issn = "1071-3581",
publisher = "Springer New York",
number = "2",

}

TY - JOUR

T1 - Estimation of coronary flow reserve by sestamibi imaging in type 2 diabetic patients with normal coronary arteries

AU - Storto, Giovanni

AU - Pellegrino, Teresa

AU - Sorrentino, Anna Rita

AU - Luongo, Luca

AU - Petretta, Mario

AU - Cuocolo, Alberto

PY - 2007/4

Y1 - 2007/4

N2 - Background: We assessed coronary flow reserve (CFR) by sestamibi imaging in patients with type 2 diabetes without coronary artery disease and normal coronary vessels. Methods and Results: Dipyridamole/rest technetium 99m sestamibi imaging was performed in 33 patients with type 2 diabetes without a history of coronary artery disease and normal coronary vessels at angiography and in 12 control subjects. Myocardial blood flow (MBF) was estimated by measuring first-transit counts in the pulmonary artery and myocardial counts from tomographic images. Estimated CFR was expressed as the ratio of stress MBF to rest MBF. Rest MBF and CFR were corrected for rate-pressure product and expressed as normalized MBF and normalized CFR. At rest, estimated MBF and normalized MBF were not different in control subjects versus patients (0.98 ± 0.4 counts · pixel-1 · s-1 vs 1.42 ± 0.9 counts · pixel-1 · s-1 and 1.14 ± 0.5 counts · pixel-1 · s-1 vs 1.61 ± 0.9 counts · pixel-1 · s-1, respectively). Conversely, stress MBF was higher in control subjects than in patients (2.34 ± 0.8 counts · pixel-1 · s-1 vs 1.55 ± 0.8 counts · pixel-1 · s-1, P <.01). Thus estimated CFR was higher in control subjects than in patients (2.40 ± 0.3 vs 1.36 ± 0.8, P <.0001). After correction for the rate-pressure product, normalized CFR was still higher in control subjects than in patients (2.10 ± 0.5 vs 1.28 ± 0.8, P <.001). Conclusions: Sestamibi imaging may detect impaired coronary vascular function in response to dipyridamole in type 2 diabetic patients without a history of coronary artery disease and with normal coronary arteries.

AB - Background: We assessed coronary flow reserve (CFR) by sestamibi imaging in patients with type 2 diabetes without coronary artery disease and normal coronary vessels. Methods and Results: Dipyridamole/rest technetium 99m sestamibi imaging was performed in 33 patients with type 2 diabetes without a history of coronary artery disease and normal coronary vessels at angiography and in 12 control subjects. Myocardial blood flow (MBF) was estimated by measuring first-transit counts in the pulmonary artery and myocardial counts from tomographic images. Estimated CFR was expressed as the ratio of stress MBF to rest MBF. Rest MBF and CFR were corrected for rate-pressure product and expressed as normalized MBF and normalized CFR. At rest, estimated MBF and normalized MBF were not different in control subjects versus patients (0.98 ± 0.4 counts · pixel-1 · s-1 vs 1.42 ± 0.9 counts · pixel-1 · s-1 and 1.14 ± 0.5 counts · pixel-1 · s-1 vs 1.61 ± 0.9 counts · pixel-1 · s-1, respectively). Conversely, stress MBF was higher in control subjects than in patients (2.34 ± 0.8 counts · pixel-1 · s-1 vs 1.55 ± 0.8 counts · pixel-1 · s-1, P <.01). Thus estimated CFR was higher in control subjects than in patients (2.40 ± 0.3 vs 1.36 ± 0.8, P <.0001). After correction for the rate-pressure product, normalized CFR was still higher in control subjects than in patients (2.10 ± 0.5 vs 1.28 ± 0.8, P <.001). Conclusions: Sestamibi imaging may detect impaired coronary vascular function in response to dipyridamole in type 2 diabetic patients without a history of coronary artery disease and with normal coronary arteries.

KW - Coronary flow reserve

KW - single photon emission computed tomography imaging

KW - type 2 diabetes mellitus

UR - http://www.scopus.com/inward/record.url?scp=33947434096&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33947434096&partnerID=8YFLogxK

U2 - 10.1016/j.nuclcard.2006.12.327

DO - 10.1016/j.nuclcard.2006.12.327

M3 - Article

C2 - 17386381

AN - SCOPUS:33947434096

VL - 14

SP - 194

EP - 199

JO - Journal of Nuclear Cardiology

JF - Journal of Nuclear Cardiology

SN - 1071-3581

IS - 2

ER -